In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species - Université Paris-Est-Créteil-Val-de-Marne
Article Dans Une Revue Antimicrobial Agents and Chemotherapy Année : 2017

In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species

Saeed Emami
  • Fonction : Auteur
Afsane Vaezi
  • Fonction : Auteur
Seyedeh Mahdieh Hashemi
  • Fonction : Auteur
Leila Faeli
  • Fonction : Auteur
Kambiz Diba
  • Fonction : Auteur
Hamid Badali

Résumé

ABSTRACT The in vitro activities of two novel azole compounds (aryl-1,2,4-triazol-3-ylthio analogues of fluconazole [ATTAFs]) and five comparator antifungal agents against 52 clinical Candida isolates from 5 different species were determined. The novel azole compounds had the lowest geometric mean MICs, followed by fluconazole. Moreover, combinations of these compounds with fluconazole exhibited synergistic effects against fluconazole-susceptible (22 of 23 isolates), fluconazole-susceptible dose-dependent (10 of 13 isolates), and fluconazole-resistant (1 of 16 isolates) Candida isolates.
Fichier principal
Vignette du fichier
fakhim-et-al-2016-in-vitro-activities-of-novel-azole-compounds-attaf-1-and-attaf-2-against-fluconazole-susceptible-and.pdf (262.94 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03997772 , version 1 (04-09-2024)

Identifiants

Citer

Hamed Fakhim, Saeed Emami, Afsane Vaezi, Seyedeh Mahdieh Hashemi, Leila Faeli, et al.. In Vitro Activities of Novel Azole Compounds ATTAF-1 and ATTAF-2 against Fluconazole-Susceptible and -Resistant Isolates of Candida Species. Antimicrobial Agents and Chemotherapy, 2017, 61 (1), ⟨10.1128/AAC.01106-16⟩. ⟨hal-03997772⟩

Collections

UPEC
8 Consultations
2 Téléchargements

Altmetric

Partager

More